CLN-978, a novel half-life extended CD19/CD3/HSA-specific T cell-engaging antibody construct with potent activity against B-cell malignancies with low CD19 expression
======================================================================================================================================================================

* Kristan Meetze
* Naveen K Mehta
* Bochong Li
* Hannah M Findlay
* Timothy B London
* Agapitos Patakas
* Jennifer S Michaelson
* Patrick A Baeuerle